Bray RA - Search Results

1

Racial differences in the development of de-novo donor-specific antibodies and treated antibody-mediated rejection after heart transplantation.

Cole RT, Gandhi J, Bray RA, Gebel HM, Yin M, Shekiladze N, Young A, Grant A, Mahoney I, Laskar SR, Gupta D, Bhatt K, Book W, Smith A, Nguyen D, Vega JD, Morris AA. Cole RT, et al. Among authors: bray ra. J Heart Lung Transplant. 2018 Apr;37(4):503-512. doi: 10.1016/j.healun.2017.11.003. Epub 2017 Nov 4. J Heart Lung Transplant. 2018. PMID: 29198929

2

Discordant expression of CD3 and T-cell receptor antigens on lymphocytes from patients treated with OKT3.

Gebel HM, Lebeck LL, Jensik SC, Landay AL, Bray RA. Gebel HM, et al. Among authors: bray ra. Transplant Proc. 1989 Feb;21(1 Pt 2):1745-6. Transplant Proc. 1989. PMID: 2523590 No abstract available.

3

The flow cytometric crossmatch. Dual-color analysis of T cell and B cell reactivities.

Bray RA, Lebeck LK, Gebel HM. Bray RA, et al. Transplantation. 1989 Nov;48(5):834-40. Transplantation. 1989. PMID: 2815255

4

Sensitization and sensitivity: defining the unsensitized patient.

Gebel HM, Bray RA. Gebel HM, et al. Among authors: bray ra. Transplantation. 2000 Apr 15;69(7):1370-4. doi: 10.1097/00007890-200004150-00027. Transplantation. 2000. PMID: 10798756

5

Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection.

Tambur AR, Bray RA, Takemoto SK, Mancini M, Costanzo MR, Kobashigawa JA, D'Amico CL, Kanter KR, Berg A, Vega JD, Smith AL, Roggero AL, Ortegel JW, Wilmoth-Hosey L, Cecka JM, Gebel HM. Tambur AR, et al. Among authors: bray ra. Transplantation. 2000 Oct 15;70(7):1055-9. doi: 10.1097/00007890-200010150-00011. Transplantation. 2000. PMID: 11045642

6

Flow PRA to detect clinically relevant HLA antibodies.

Gebel HM, Bray RA, Ruth JA, Zibari GB, McDonald JC, Kahan BD, Kerman RH. Gebel HM, et al. Among authors: bray ra. Transplant Proc. 2001 Feb-Mar;33(1-2):477. doi: 10.1016/s0041-1345(00)02100-x. Transplant Proc. 2001. PMID: 11266916 No abstract available.

7

Low-resolution HLA class II typing for solid organ transplantation is inadequate.

Bray RA, Gebel HM. Bray RA, et al. Transplant Proc. 2001 Feb-Mar;33(1-2):500. doi: 10.1016/s0041-1345(00)02110-2. Transplant Proc. 2001. PMID: 11266926 No abstract available.

8

Conundrums with FlowPRA beads.

Gebel HM, Harris SB, Zibari G, Bray RA. Gebel HM, et al. Among authors: bray ra. Clin Transplant. 2002;16 Suppl 7:24-9. doi: 10.1034/j.1399-0012.16.s7.3.x. Clin Transplant. 2002. PMID: 12372040

9

Anti-CD40 therapy extends renal allograft survival in rhesus macaques.

Pearson TC, Trambley J, Odom K, Anderson DC, Cowan S, Bray R, Lin A, Hollenbaugh D, Aruffo A, Siadak AW, Strobert E, Hennigar R, Larsen CP. Pearson TC, et al. Transplantation. 2002 Oct 15;74(7):933-40. doi: 10.1097/00007890-200210150-00006. Transplantation. 2002. PMID: 12394833

10

Pre-transplant assessment of donor-reactive, HLA-specific antibodies in renal transplantation: contraindication vs. risk.

Gebel HM, Bray RA, Nickerson P. Gebel HM, et al. Among authors: bray ra. Am J Transplant. 2003 Dec;3(12):1488-500. doi: 10.1046/j.1600-6135.2003.00273.x. Am J Transplant. 2003. PMID: 14629279 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

300 results

Search Page